Imgenex廠家致力于發(fā)展和生產(chǎn)人體生理和疾病狀態(tài)的研究試劑、人類疾病的診斷試劑和治療試劑。這些新的試劑包括抗體、基因、蛋白表達系統(tǒng)、用于人類功能基因組研究的各種細胞和組織的陣列。涉及領(lǐng)域包括癌癥、凋亡、信號途徑、細胞衰老、代謝和感染等疾病。
其中，最有特色的是發(fā)展了SARS的抗體。
2013年Novus Biologicals收購Imgenex

 




  
      
Imgenex Corp. develops and commercializes novel reagents for the scientific study of human biology and disease and for the production of new diagnostic assays and potential therapies of such diseases. These novel reagents include antibodies, gene and protein expression systems, and arrays of various cells and tissues for use in studies of functional genomics. Areas of biological interest at IMGENEX include cancer, apoptosis (programmed cell death), molecular signaling pathways, cellular aging, and metabolic and infectious diseases. Our corporate office is located in Sorrento Valley, in close proximity to the University of California at San Diego, The Salk Institute and The Scripps Research Institute.